title: Midface injectable fillers: have they replaced midface surgery?
abstract: This article examines the increasing role of injectable fillers to treat midface aging and our approach to decision making regarding the use of fillers versus surgery. We discuss the volume changes of the aging midface and advocate taking an anatomic approach to correct these changes. We discuss our approach to patient selection and injection technique. Finally, we review potential complications from injectable fillers and discuss the management of complications.
authors.affiliation: Facial Plastic and Reconstructive Surgery, Williams' Center of Plastic Surgery Specialists, Latham, NY 12110, USA. allisonpontius@ymail.com
authors.forename: Allison T
authors.initials: AT
authors.lastname: Pontius
authors.forename: Scott R
authors.initials: SR
authors.lastname: Chaiet
authors.forename: Edwin F
authors.initials: EF
authors.lastname: Williams
mesh_terms: D001672:Biocompatible Materials / Q000008:administration & dosage* / Q000009:adverse effects; D002482:Cellulose / Q000008:administration & dosage* / Q000009:adverse effects; D003357:Cosmetic Techniques / Q000009:adverse effects; D017886:Durapatite / Q000008:administration & dosage* / Q000009:adverse effects; D005145:Face / Q000601:surgery; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D007279:Injections, Subcutaneous; D019344:Lactic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D008353:Mannitol / Q000008:administration & dosage* / Q000009:adverse effects; D019060:Minimally Invasive Surgical Procedures; D018579:Patient Selection; D011300:Preoperative Care; D012060:Rejuvenation; D015361:Rhytidoplasty / Q000379:methods
chemical_list: D001672:Biocompatible Materials; C482305:New-Fill; D019344:Lactic Acid; D008353:Mannitol; D002482:Cellulose; D006820:Hyaluronic Acid; D017886:Durapatite